Results 31 to 40 of about 36,199 (325)

Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned

Pharmacoepidemiology and Drug Safety, 2023
We assessed the suitability of pooled electronic health record (EHR) data from clinical research networks (CRNs) of the patient‐centered outcomes research network to conduct studies of the association between tumor necrosis factor inhibitors (TNFi) and ...
T. Beukelman, Lang Chen, N. Annapureddy, J. Oates, M. Clowse, M. Long, M. Kappelman, Rennie L. Rhee, Peter A Merkel, W. B. Nowell, F. Xie, C. Clinton, J. Curtis   +12 more
semanticscholar   +1 more source

The promotion of data sharing in pharmacoepidemiology [PDF]

, 2014
This article addresses the role of pharmacoepidemiology in patient safety and the crucial role of data sharing in ensuring that such activities occur. Against the backdrop of proposed reforms of European data protection legislation, it considers whether ...
Sethi, Nayha
core   +1 more source

Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations. [PDF]

Pharmacotherapy
Abstract The use and misuse of opioids has surged in the past decade, with nearly half of the users being female. Although opioid use is lower among pregnant women, trends mirror the general population. While pediatric exposures largely occur through prescriptions.
Shendre A, Liu X, Chiang C, Goodwin A, Oteng SR, Deypalubos JAF, Zhang S, Wang L, Liu J, Abbasi MY, Aruldhas BW, Zaidi SS, Kirkpatrick LM, Silva LD, Overholser BR, O'Kane AM, Kannankeril PJ, Patrick SW, Wiese AD, Quinney SK, Li L.   +20 more
europepmc   +2 more sources

Needs and priority areas for building capacity for working with linked data in the Australian pharmacoepidemiology workforce

International Journal of Population Data Science, 2018
Introduction Linked data are increasingly used in pharmacoepidemiology studies to enhance value beyond that which can be achieve from stand-alone pharmaceutical data. The complexity of pharmaceutical data can make any linked data analysis challenging and
Derrick Lopez, Benjamin Daniels, Frank Sanfilippo, Sallie Pearson, Angelita Martini, David B Preen   +5 more
doaj   +1 more source

Drug Prescriptions during Pregnancy in Lombardy: Temporal Trends and the Impact of the Onset of the COVID-19 Pandemic

Pharmacoepidemiology, 2023
This population-based study aimed at providing an overview of drug prescription patterns during pregnancy in the Italian region of Lombardy from 2010 to 2020.
Giovanna Esposito, Anna Cantarutti, Matteo Franchi, Giovanni Corrao, Fabio Parazzini   +4 more
doaj   +1 more source

Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual‐level drug dispensing data

Pharmacoepidemiology and Drug Safety, 2022
Drug utilization studies are essential to facilitate rational drug use in the society.
L. Rasmussen, B. Wettermark, D. Steinke, A. Pottegård   +3 more
semanticscholar   +1 more source

The experience of accommodating privacy restrictions during implementation of a large-scale surveillance study of an osteoporosis medication. [PDF]

, 2016
PurposeTo explore whether privacy restrictions developed to protect patients have complicated research within a 15-year surveillance study conducted with US cancer registries.MethodsData from enrolling 27 cancer registries over a 10-year period were ...
Andrews, Elizabeth B, Deapen, Dennis M, Gilsenan, Alicia W, Harris, David H, Hornicek, Francis J, Midkiff, Kirk D, Schymura, Maria J   +6 more
core   +1 more source

COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective

Pharmacoepidemiology, 2023
More than 3 years have passed since the emergence of COVID-19. On 8 May 2023, COVID-19 in Japan was downgraded to Category 5 by the Infectious Disease Control Law. In Japan, at the beginning of the COVID-19 pandemic in 2020, cases of infection and deaths
Hiroshi Kusunoki
doaj   +1 more source

Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting

Pharmacoepidemiology and Drug Safety, 2022
Transparency is increasingly promoted to instill trust in nonrandomized studies using real‐world data. Graphics and data visualizations support transparency by aiding communication and understanding, and can inform study design and analysis decisions ...
N. Gatto, Shirley V. Wang, W. Murk, P. Mattox, M. A. Brookhart, A. Bate, S. Schneeweiss, J. Rassen   +7 more
semanticscholar   +1 more source

Signal Detection Study Focusing on Differences in the Drug Delivery System of Oral 5-Aminosalicylate for Inflammatory Bowel Disease Using the Japanese Pharmacovigilance Database

Pharmacoepidemiology, 2023
Although 5-Aminosalicylate (5-ASA) has been shown to act on the local mucosa, when 5-ASA is orally administered, most of it is absorbed in the upper gastrointestinal tract and does not reach the large intestine, where lesions are present.
Yoshihiro Noguchi, Shuji Yamashita, Hirofumi Tamaki, Arihiro Osanai, Yoko Ino, Tomoya Tachi, Kazuhiro Iguchi, Hitomi Teramachi   +7 more
doaj   +1 more source